Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
HAEMATOLOGY REPORT
Test Description Result Unit Biological Reference Ranges
COMPLETE BLOOD COUNT
Haemoglobin 15.4 gm/dL 12.0 - 16.0
Total WBC Count 6600 cell/cu.mm 4000 - 11000
RBC Count 4.67 mil/cu.mm 3.8 - 4.8
RBC INDICES
Hematocrit HCT 42.4 % 36 - 46
Mean Corp Volume MCV 90.8 fL 83 - 101
Mean Corp Hb MCH 33.0 pg 27 - 32
Mean Corp Hb Conc MCHC 36.3 gm/dL 31.5 - 34.5
Platelet Count 2.10 Lac/cmm 1.5 - 4.5
ESR
Esr 09 mm/hr 0 - 07
Method: Westergren
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 52 % 40 - 75
Lymphocytes 43 % 20 - 40
Monocytes 03 % 02 - 08
Eosinophils 02 % 01 - 04
Basophils 00 % 00 - 01
Peripheral Blood Smear
RBC Morphology Red Blood Cells are Normocytic Normochromic.
WBC Morphology Total Leucocyte Count is Normal for age.
Differential Leucocyte Count is normal in number and morphology.
Platelet on smear Platelet are normal in number and morphology.
IMPRESSION: NORMAL BLOOD PICTURE.
NOTE:
1. As per the recommendation of International council for Standardization in Hematology, the differential leukocyte counts are
additionally being reported as absolute numbers of each cell in per unit volume of blood.
2. Test conducted on EDTA whole blood.
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 1 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
BIOCHEMISTRY REPORT
Test Description Result Unit Biological Reference Ranges
KIDNEY FUNCTION TEST(KFT)
Urea 27.47 mg/dl 10.0 - 45.0
Method: Urease UV GLDH
Serum Creatinine 0.82 mg/dL 0.70 - 1.20
Method: Modified Jaffe with no deproteinzation
Uric Acid 5.16 mg/dl 3.6 - 7.7
Method: Uricase Peroxidase
Blood Urea Nitrogen-BUN 12.8 mg/dl 7 - 21
Method: Calculated
eGFR 124 ml/min 0 - 90
Interpretation :
Kidney function tests help to screen the individual for renal disease and to determine the extent or progression of renal disease.
These tests also aid in determining drug dosage for drugs excreted through the kidneys. The clinical syndrome resulting from
decreased renal function and azotemia is called uremia Renal azotemia: glomerular nephritis and chronic pyelonephritis. Prerenal
azotemia: severe dehydration, hemorrhagic shock, and excessive protein intake. Post renal azotemia: urethral stones or tumors
and prostatic obstructions Measurement of urea in dialysis fluids is widely used in assessing the adequacy of renal replacement
therapy.
In these prerenal situations, the plasma creatinine concentration may be normal.In obstructive post renal conditions, both plasma
creatinine and urea concentrations will be increased, although there is often a greater increase in plasma urea than creatinine
because of the increased back diffusion.These considerations give rise to the principal clinical utility of plasma urea, which lies in
its measurement in conjunction with that of plasma creatinine and subsequent calculation of the urea nitrogen/creatinine ratio.
This ratio has been used as a crude discriminator between prerenal and postrenal azotemia. Significantly lower ratios usually
denote (1) acute tubular necrosis, (2) low protein intake, (3) starvation, or (4) severe liver disease (decreased urea synthesis). So
even though blood urea is not an excellent marker of renal dysfunction as it rises quite late in the dysfunction and its rise is also
not exclusive to kidney dysfunction, but for practical purposes serum urea level is still one of the most ordered test and forms an
important part of the kidney function test.
Concentrations in excess of 6.0 mg/dL at 32 weeks gestation have been noted to be associated with a high perinatal mortality
rate.
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 2 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
BIOCHEMISTRY REPORT
Test Description Result Unit Biological Reference Ranges
LIPID PROFILE
Cholesterol-Total 164.7 mg/dL < 200 - Desirable
Method: Spectrophotometry 200 - 239 -Boderline High
> 240 - High
Triglycerides level 107.5 mg/dL < 150 - Normal
Method: Serum, Enzymatic, endpoint 150 - 199 -Boderline High
200 - 499 -High
>500 Very -High
HDL Cholesterol 52.6 mg/dL < 40 - Low
Method: Serum, Direct measure-PEG > 40 - Normal
LDL Cholesterol 90.60 mg/dL < 100 - Optimal
Method: Enzymatic selective protection 100 - 129 - Near/Above
Optimal
130 - 159 - Borderline high
160 - 189 - High
> 190 - Very High
VLDL Cholesterol 21.50 mg/dL 6 - 38
Method: Serum, Enzymatic
CHOL/HDL RATIO 3.13 3.5 - 5.0
Method: Serum, Enzymatic
LDL/HDL RATIO 1.72 2.5 - 3.5
Method: Serum, Enzymatic
NOTE
8-10 hours fasting sample is required
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 3 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
BIOCHEMISTRY REPORT
Test Description Result Unit Biological Reference Ranges
LIVER FUNCTION TEST (LFT)
TOTAL BILIRUBIN 0.61 mg/dl 0.0 - 1.2
Method: Serum, Jendrassik Grof
DIRECT BILIRUBIN 0.18 mg/dL 0.0 - 0.3
Method: Serum, Diazotization
INDIRECT BILIRUBIN 0.43 mg/dl 0.2 - 9.8
Method: Serum, Calculated
SGPT (ALT) 28.1 U/L 0 - 42
Method: Serum, UV with P5P, IFCC 37 degree
SGOT (AST) 20.1 U/L 0 - 37
Method: Serum, UV with P5P, IFCC 37 degree
ALKALINE PHOSPHATASE 52.1 U/L 53 - 128
Method: DGKC
TOTAL PROTEIN 6.6 g/dl 6.0 - 8.0
Method: Serum, Biuret, reagent blank end point
SERUM ALBUMIN 4.2 g/dl 3.2 - 4.6
Method: Serum, Bromocresol green
SERUM GLOBULIN 2.40 g/dl 1.8 - 3.6
Method: Serum, Calculated
A/G RATIO 1.75 1.2 - 2.2
Method: Serum, Calculated
NOTE :
In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or Non alcoholic fatty liver disease,
Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 4 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
IMMUNOASSAY REPORT
Test Description Result Unit Biological Reference Ranges
Thyroid Stimulating Hormone(TSH)- 3.96 mIU/mL 0.37 - 5.4
Serum
Method : ECLIA
INTERPRETATION
Biological Reference Ranges : TSH(mIU/mL)
0 - 6 days 0.7 - 15.2 Pregnancy As per American Thyroid Association
>6 days - < 3 months 0.72 - 11.0 1 Trimester 0.33 - 4.59
> 3 - < 12 months 0.73 -8.35 2 Trimester 0.35 -4.1
> 1 - < 6 yrs 0.7 -5.97 3 Trimester 0.21 - 3.15
> 6 - <11 yrs 0.6- 4.84
>11 - < 20 yrs 0.51 -4.3
> 20 - 100 Yrs 0.27-4.2
Interpretations:
* Assay result should be interpreted in context to the clinical condition and associated result of the other
investigation.
* Previous treatment with corticosteroid therapy may result in lower TSH levels while thyroid hormone levels are
normal.
* Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test.
* Abnormal thyroid test findings often found in critically ill clients should be repeated after the critical nature of
the condition is resolved.
* The production circulation and disposal of thyroid hormones are altered throughout the stages of pregnancy.
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 5 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
URINE EXAMINATION REPORT
Test Description Result Unit Biological Reference Ranges
URINE ROUTINE R/M
Physical Examination
Quantity 20ml, ml
Colour Pale Yellow Pale Yellow
Apperance Clear Clear
Specific Gravity 1.020,
Chemical Examination
Sugar NIL Absent
Protein Absent Absent
Reaction(pH) 6.5 4.5 - 8.0
Microscopic Examination
Bacteria Not seen Not Seen
Epithelial Cells 1-2/hpf /hpf 1-2/hpf
Pus cells 1-2/hpf /hpf 2-3/hpf
RBC's NIL /hpf Nil
Casts NOT FOUND Not Seen
Crystals NOT FOUND Absent
Yeast Cells NOT FOUND Not seen
Other Finding -
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 6 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
Amorphous Deposit NOT FOUND Absent
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 7 of 8
Patient ID : ASL24/6447 Sample ID : 2410384
Name : MR SHIV RAJ Registration Date : 12/10/2024 11:52 AM
Age/Gender : 24 Yrs/Male Report Date : 12/10/2024 05:02 PM
Ref. Dr. :
Test Description Result Unit Biological Reference Ranges
Fasting Plasma Glucose 75.4 mg/dl 60 - 110
Method: Hexokinase
ADA 2019 Guidelines:
Normal: 70-100
Impaired Fasting Glucose(IFG): 100-125
Diabetes mellitus: >= 126
(on more than one occassion)
**** End of the report. ****
Please correlate clinically.
Checked By Dr. Nikhat Mirza
SENIOR LAB TECHNICIAN M.B.B.S., DCP
TANWIR ALAM Consultant Pathologist
Reg No. 74902
Page 8 of 8
